Walgreens Boots Alliance inks deal with McKesson Corporation

Walgreens Boots Alliance inks deal with McKesson Corporation

Date: 2019-12-14 By Saipriya Iyer

Walgreens Boots Alliance, an American holding company headquartered in Illinois inked a deal with Mckesson Corporation, a German healthcare and pharmaceutical company to transpire a joint venture (JV) which will bolster their respective pha....

Walgreens and Kroger to form a new group purchasing venture

Walgreens, a renowned U.S. based pharmacy-led health, beauty and well-being company, and Kroger, an American retail company, reportedly announced that they would be expanding their existing relationship to create a new group purchasing orga....

Amphivena announces initial data from Phase 1 study of AMV564

Amphivena Therapeutics, Inc., a clinical stage immuno-oncology firm developing T cell engager therapies for cancer, has recently presented data from Phase 1 trial of AMV564, a bivalent T cell engager clinical candidate, at the American Soci....

Sanofi to acquire biotechnology firm Synthorx for $2.5 billion

Sanofi, a renowned France based multinational pharmaceutical company, reportedly announced that it would be acquiring California based biotechnology firm, Synthorx, for $2.5 billion. Sanofi offered to purchase all outstanding shares of Synt....

GE Healthcare Life Sciences & ASLS unite to advance 3D biofabrication

  The alliance is aimed at personalizing regenerative tissue manufacturing processes Vascularized printed cells are set to pave the way for more complex biological structures including soft tissue, organ replacements and bone GE H....

uniQure updates follow up-data from hemophilia B therapy trials

uniQure N.V, a renowned gene therapy firm that advances evolving therapies for all the patients who have severe medical needs, has recently confirmed that it has updated clinical data on three patients who were treated in the company’....

Hummingbird Bio secures $19M to expand antibody therapeutics portfolio

Hummingbird Bioscience, an advanced biotherapeutics company, recently announced it has raised USD 19 million in a Series B funding round. Apparently, the financing round was co-led by GNTech Venture Capital and Mirae Asset Venture Investmen....

Industry Updates